Angela Lai former Founder of Betteromics (former CTO of GRAIL) on Building Software for the Life Science Industry and What The World Doesn't know About Big Pharma

In this episode, David Paul interviews Angela Lai, the founder and CEO of Betteromics. They discuss Angela's background in the tech industry and her transition to the life sciences business. They explore the intersection of biology, chemistry, big data, and AI in the field of healthcare science. Angela explains how Betteromics serves as a regulated data lake for healthcare science data, providing a system of record and interoperability for clinical discovery. They also discuss the challenges and opportunities in the life science industry, the future of pharma and personalized medicine, and the importance of transparency and storytelling in the industry. Angela shares her insights as a founder and the personal growth she has experienced in building a startup. You can watch/listen to the podcast on YouTube, Spotify, and Apple. TakeawaysThe life science industry is undergoing a transformation as biology, chemistry, big data, and AI converge.Betteromics serves as a regulated data lake for healthcare science data, providing a system of record and interoperability for clinical discovery.The life science industry faces challenges in data fragmentation, data governance, and the need for more efficient and predictable drug development.Specialty pharma medicines, personalized medicine, and biologics are the future of the industry.Founding a startup requires versatility, problem-solving skills, and a willingness to learn and adapt. Chapters 02:08 Transition from Google to Grail to Betteromics 03:32 The Intersection of Biology, Chemistry, Big Data, and AI 06:06 Betteromics as a Regulated Data Lake for Healthcare Science 09:08 Challenges in the Life Science Industry 12:18 Positioning Betteromics in the Market 16:23 The Future of Pharma and Life Science 19:40 Technological Advances Enabling Betteromics 22:52 The Success Rate of Drugs and Therapies 28:14 The Opacity of the Life Science Industry 31:17 The Rise of Specialty Pharma Medicines 34:30 Lessons Learned as a Founder 37:49 Personal Growth and Privilege